Louise Rosmer, on Behalf of Herself and as Class Representative v. Pfizer IncorporatedLouise Rosmer, on Behalf of Herself and as Class Representative v. Pfizer Incorporated
Lead Opinion
ORDER
Appellant filed a petition for rehearing and rehearing en banc.
On the petition for rehearing, Chief Judge Wilkinson and Judge Hall (SUSCJ, 9CCA) voted to deny. Judge Motz voted to grant.
A member of the Court requested a poll on whether this case should be reheard en banc. The poll did not attract a majority of the judges in active service.
Chief Judge Wilkinson filed an opinion concurring in the denial of rehearing en banc. Judge Niemeyer filed an opinion dissenting from the denial of rehearing en banc. Judge Motz filed an opinion dissenting from the denial of rehearing en banc, in which Judge Luttig joined.
The petition for rehearing and rehearing en banc are hereby denied. Entered at the direction of Chief Judge Wilkinson for the Court.
Concurrence Opinion
concurring in the denial of rehearing en banc.
The panel majority opinion sets out at length my view of the proper interpretation of
Some of the dissent’s objections are different from those expressed in the dissent from the panel majority opinion. See Ros-mer,
I.
The dissent’s approach rests in unadorned fashion upon two premises. The first is that diversity is a disfavored form of federal jurisdiction. And the second is that Rule 23 is a disfavored rule in the Federal Rules of Civil Procedure. The dissent objects that the majority opinion “substantially expand[s] diversity jurisdiction in the federal courts.” Post at 247. It reiterates that “[b]y opening federal courts to virtually every class action involving state law, the panel opinion broadly expands federal jurisdiction in diversity cases.” Post at 248. It submits that the majority opinion’s reading of
Continuing its policy brief, the dissent observes that diversity jurisdiction “inherently ... comes into tension with the traditional division of judicial responsibility between the states and the federal government.” Post at 253. “And for that reason, and other more pragmatic ones,” it explains, “diversity jurisdiction has never been favored with aggressive expansion, either by Congress or the courts.” Post at 253. “Indeed,” it relates, “over the years, Congress has continually and without exception taken modest steps to limit the scope of diversity jurisdiction in this sensi
The consequences of the two candidly stated premises that animate these policy prescriptions are quite remarkable. We are being asked to arrogate unto ourselves, under the guise of interpretive maxims or otherwise, the authority to establish the parameters of our own jurisdiction. This is fundamentally at odds with the separation of powers and the constitutional scheme.
Whether we like it or not, Congress has long had the authority to set the bounds of federal jurisdiction. See
II.
The text and statutory structure of
The dissent advances a number of suggestions as to how we might accomplish the insertion of
The problems with this objection are manifold. First, as the majority opinion states, see Rosmer,
In addition,
The dissent next advances the novel argument that the supplemental claims of the unnamed class members are not part of the same constitutional case under United Mine Workers v. Gibbs,
To my knowledge, this suggestion has not been advanced by any other judge or court. The dissent cites no specific authority to support it. Instead, it states that “all the jurisprudence of
Indeed, the dissent states that “[tjhere is no constitutional requirement prohibiting two constitutional cases from being adjudicated simultaneously, and the simultaneous prosecution of similar claims for judicial efficiency is the justification for
The dissent claims that “the constitutionally distinct nature of the claims aggregated under
In addition, the dissent’s view of class actions is flatly inconsistent with the Supreme Court’s decision in Supreme Tribe of Ben-Hur v. Cauble,
Not only is there a lack of authority to support the dissent’s view of class actions, but its position also generates perverse implications from its own perspective. The dissent purports to desire to limit the scope of the class action device, accusing the panel majority in Rosmer of “in-creas[ing] vastly the power of federal class actions, all at the expense of the states’ long-standing privilege to decide state-law cases in their own courts.” Post at 253. But in freeing the claims of absent class members from the case or controversy requirement, the dissent opens the jurisdictional doors in federal class actions wide open. The dissent is the unwitting advocate of expanding the use of class actions in federal court.
The dissent’s next contention is that “Congress would never even have considered adding
The dissent’s final plea is that we consult the legislative history. This argument has already been canvassed at length in Rosmer. See
III.
I may well share the dissent’s policy predilections. What I absolutely do not share, however, is the view that our notions of federal jurisdiction trump those of the coordinate branch of government to which such questions are constitutionally entrusted. We are being called upon to express our policy preferences against diversity jurisdiction and against class actions by the bald amendment of a statute from the bench. We are being asked quite transparently to insert the words “
Dissenting Opinion
dissenting.
On the poll to rehear this case en banc, three members of the court unfortunately found themselves unable to participate, leaving a four-four vote and denying the possibility that the court en banc can reconsider this important case. Because I
I
Louise Rosmer, on behalf of herself and a class of all persons similarly situated, filed this class action against Pfizer, Incorporated, in South Carolina state court, for injury caused by the antibiotic Trovan. She asserted only state-law causes of action. When Pfizer removed the case to federal court, relying on diversity jurisdiction under
The district court denied Rosmer’s motion to remand and retained jurisdiction over the case, concluding that it had diversity jurisdiction over Rosmer’s individual claim against Pfizer and that it had supplemental jurisdiction, under
The panel opinion, which has thus been left standing, holds that, in a class action,
When it adopted
II
No one disputes that Congress enacted
Pendent jurisdiction, in the sense of judicial power, exists whenever there is a claim “arising under [the] Constitution, the Laws of the United States, and Treaties made, or which shall be made, under their Authority ...,”U.S. Const., Art. Ill, § 2 , and the relationship between that claim and the state claim permits the conclusion that the entire action before the court comprises but one constitutional “case. ” ... The state and federal claims must derive from a common nucleus of operative fact.
Id. (emphasis added).
While
The statutory grant of supplemental jurisdiction applies only to “civil aetion[s] of which the district courts have original jurisdiction.”
The panel opinion, through a sleight of analytical hand, avoids the first step by converting Rosmer’s class action claim into an individual claim to create original jurisdiction and then adding back the absent class action members’ claims as “supplemental” claims.
Unlike the other forms of aggregation permitted under the Federal Rules — im-pleader, joinder, and intervention —
Accordingly, when determining whether the court has original jurisdiction over the “civil action” — in this ease a
Ill
Even if we assume that the “take-it-apart and put-it-back-together” end-run around the original jurisdiction requirement in
Indeed, the constitutionally distinct nature of the claims aggregated under
As a codification of Gibbs,
The holding in Zahn, of course, does not say that a class action authorized under
The panel opinion ignores this understanding of
IV
The panel majority also relies, for its conclusion, on the fact that, in
Contrary to the panel majority’s assertion, the absence of
To read a repeal of Zahn by implication, based on the ground that
V
The panel opinion also refuses to consult the legislative history, concluding that the language of
While I assert in this opinion that a natural reading of
By dismissing this legislative history with the assertion that the statutory lan
VI
Over the years, diversity jurisdiction has served a useful role in providing an alternative forum for state-law claims, particularly to avoid potential local prejudices in particular types of cases. But inherently, any such facility comes into tension with the traditional division of judicial responsibility between the states and the federal government. And for that reason, and other more pragmatic ones, diversity jurisdiction has never been favored with aggressive expansion, either by Congress or the courts. Indeed, over the years, Congress has continually and without exception taken modest steps to limit the scope of diversity jurisdiction in this sensitive area of federalism.
Lacking a sensitivity for this overarching policy in the federal structure, the panel majority in this case not only amplifies manyfold the circumstances in which diversity jurisdiction is available, but also increases vastly the power of federal class actions, all at the expense of the states’ long-standing privilege to decide state-law cases in their own courts.
This decision is a momentous mistake, and I respectfully dissent from the decision of our court not to rehear this case en banc.
Notes
. It is curious that my good colleague’s opinion concurring in the refusal to hear this case en banc states on the one hand that, as used in
Of course, a class action is one civil action. See
. The categorization, in Zahn, of 23(b)(3) class actions as an aggregation of separate suits would likely also require complete diversity among 23(b)(3) class members, as per Strawbridge v. Curtiss,
. The concurring opinion continues this misunderstanding of
Dissenting Opinion
dissenting from the denial of rehearing en banc.
I voted to rehear this case for the reasons set forth in my panel dissent. See Rosmer v. Pfizer Inc.,